US Endoscopy recognizes Dr. David L. Carr-Locke for 1 million needles sold

Last month, US Endoscopy celebrated a milestone occasion of selling 1 million Carr-Locke injection needles worldwide. We recently had the opportunity to recognize David L. Carr-Locke, MD for his collaborative partnership in the design and commercialization of the Carr-Locke injection needle by presenting him with a special award in New York City.

Introduced in 2001, the Carr-Locke injection needle is designed to address a variety of injection therapy needs including sclerotherapy, hemostasis, tattooing and submucosal injection.

Today, the Carr-Locke technology is world-renowned for its reliable and consistent performance during everyday use, as well as difficult therapeutic procedures.